À propos
Partner and patent attorney in Mewburn Ellis LLP's Life Sciences department, specialising in drafting, prosecution and oppositions for life sciences matters and advising on due diligence, freedom-to-operate and IP strategy. She has expertise in immunotherapy, antibody technology and peptide and nucleic acid technologies, and qualified as a Chartered Patent Attorney and a European Patent Attorney in 2019 after joining Mewburn Ellis in 2015.
Domaines d’expertise
PatentsIntellectual PropertyLife SciencesBiotechnologyPatent Prosecution
Bureau
Expertise
ImmunotherapyAntibody technologyPeptide technologiesNucleic acid technologiesPatent draftingPatent prosecutionOppositionsDue diligenceFreedom-to-OperateIP strategy
Formation
- BSc (First Class), Molecular Biology and Biochemistry, Durham University
- PhD, Durham University (specialised in the molecular mechanisms of plant root growth)
Inscriptions au barreau
- Chartered Patent Attorney (qualified 2019)
- European Patent Attorney (qualified 2019)